These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 12825573)

  • 1. Interferon alfacon-1: new preparation. Basically a me-too interferon alfa.
    Prescrire Int; 2003 Jun; 12(65):95-6. PubMed ID: 12825573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment options for patients with hepatitis C: role of pharmacists in optimizing treatment response and managing adverse events.
    Smith JP
    Pharmacotherapy; 2008 Sep; 28(9):1151-61. PubMed ID: 18752386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reversible ageusia and hyposmia induced by interferon in a patient with chronic hepatitis C].
    Irigoien Aleixandre S; Castiella Eguzkira A; Fernández Fernández FJ
    Rev Esp Enferm Dig; 2003 May; 95(5):364-8. PubMed ID: 12828524
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term outcome of chronic hepatitis C treated with interferon.
    Hadziyannis SJ; Papatheodoridis GV
    Ital J Gastroenterol Hepatol; 1999; 31(6):459-61. PubMed ID: 10575562
    [No Abstract]   [Full Text] [Related]  

  • 5. [Interferon therapy in chronic viral hepatitis; an autoimmunity dilemma].
    Gutkowski K; Gutkowska D; Bilkiewicz T
    Przegl Lek; 2007; 64(3):148-52. PubMed ID: 17941466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of the hematologic complications of hepatitis C therapy.
    Sulkowski MS
    Clin Liver Dis; 2005 Nov; 9(4):601-16, vi. PubMed ID: 16207566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence and clinical characteristics of coinfection of SENV-H among Taiwanese chronic hepatitis C patients with combination therapy of high-dose interferon-alfa and ribavirin.
    Dai CY; Chuang WL; Chang WY; Chen SC; Lee LP; Lin ZY; Hou NJ; Hsieh MY; Wang LY; Yu ML
    Antiviral Res; 2004 Oct; 64(1):47-53. PubMed ID: 15451178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of chronic viral hepatitis].
    Pedersen C; Pedersen CR
    Ugeskr Laeger; 2008 Jun; 170(24):2137-40. PubMed ID: 18565297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of chronic hepatitis C in hemophilic patients.
    Husa P; Smejkal P; Husová L; Penka M
    Acta Virol; 2004; 48(1):35-8. PubMed ID: 15230473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic hepatitis B: a wider range of therapeutic options.
    Prescrire Int; 2007 Aug; 16(90):157-62. PubMed ID: 17724844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot study of interferon gamma for chronic hepatitis C.
    Soza A; Heller T; Ghany M; Lutchman G; Jake Liang T; Germain J; Hsu HH; Park Y; Hoofnagle JH
    J Hepatol; 2005 Jul; 43(1):67-71. PubMed ID: 15913831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of combined antiviral therapy with interferon alfa and ribavirin in chronic hepatitis C patients with extrahepatic manifestations].
    Zarebska-Michaluk D; Lebensztejn DM; Kryczka W
    Przegl Epidemiol; 2007; 61(3):551-8. PubMed ID: 18069393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management and therapy of chronic hepatitis C virus infection in HIV-infected individuals.
    Mauss S
    J HIV Ther; 2007 Mar; 12(1):11-7. PubMed ID: 17589391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving anti-HCV therapy.
    Pol S; Mallet VO
    Discov Med; 2006 Oct; 6(35):187-90. PubMed ID: 17234140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interferon alfacon-1 (Advaferon): a novel synthetic interferon for the treatment of hepatitis C, its pharmacological and clinical profile].
    Yasuda S; Miyata K
    Nihon Yakurigaku Zasshi; 2002 Dec; 120(6):421-6. PubMed ID: 12528473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retreatment with human leukocyte interferon alpha of chronic hepatitis C, recurring after a first cycle with recombinant interferon.
    Carrara M; Azzurro M; Adamo S
    Ital J Gastroenterol Hepatol; 1998 Apr; 30(2):234-5. PubMed ID: 9675668
    [No Abstract]   [Full Text] [Related]  

  • 17. Pulmonary hypertension and hepatitis C virus related cirrhosis.
    Perrone C; Paroli M; Morelli S
    Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):283-4. PubMed ID: 9646225
    [No Abstract]   [Full Text] [Related]  

  • 18. [The exacerbation of psoriasis during treatment with alfa interferon].
    Pellicano R; Puiatti P; Palmas P; Rizzetto M; Ponzetto A
    Recenti Prog Med; 1997 Sep; 88(9):423. PubMed ID: 9380948
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute onset of nephrotic syndrome during interferon-alpha retreatment for chronic active hepatitis C.
    Nishimura S; Miura H; Yamada H; Shinoda T; Kitamura S; Miura Y
    J Gastroenterol; 2002; 37(10):854-8. PubMed ID: 12424571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The successful use of recombinant alfa-2 interferon in HBV-associated glomerulonephritis in a child].
    Fedorchenko SV; Ivanov DD
    Ter Arkh; 1996; 68(2):69-70. PubMed ID: 8771666
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.